Published December 1, 2023 | Version v1
Journal article Open

A COMPREHENSIVE REVIEW ARTICLE ON THE PROGRESSION OF KNOWLEDGE IN HEPATITIS B: UNVEILING THE JOURNEY FROM DISCOVERY TO TREATMENT

Authors/Creators

  • 1. Department of Microbiology, College of Science, Mustansiriyah University, Baghdad, Iraq.
  • 2. Department of Production Engineering and Metallurgy, University of Technology, Baghdad, Iraq.

Description

This review article offers a thorough and scholarly analysis of hepatitis B, encompassing its historical context, current understanding of therapeutic interventions, and various facets pertaining to the ailment. Initially, the article introduces hepatitis B and subsequently provides an elaborate historical account of its identification and exploration. Subsequently, an exhaustive discourse on the epidemiology and global ramifications of hepatitis B is expounded upon, with particular emphasis on the profound burden imposed by this ailment on a global scale. The modes of transmission and the associated risk factors pertaining to hepatitis B are meticulously scrutinized, illuminating the intricate mechanisms by which the virus is propagated. Furthermore, the article delves into a comprehensive exploration of the structure and replication cycle of the hepatitis B virus (HBV), thereby providing valuable insights into the intricate mechanisms that underlie viral infection and replication within the hepatic system. Subsequently, the clinical manifestations and disease progression associated with hepatitis B are thoroughly examined, thereby facilitating a profound comprehension of the multifaceted symptoms and outcomes associated with this infectious condition. Regarding diagnosis, the article delineates the diagnostic modalities utilized for hepatitis B, encompassing serological markers and nucleic acid tests, thereby emphasizing the pivotal significance of precise diagnosis in expediting timely intervention. Advancing further, the article delves into an exploration of treatment alternatives for both acute and chronic hepatitis B, with a specific emphasis on antiviral therapy and immune modulators that endeavor to curtail viral replication and augment the immune response against HBV. Moreover, meticulous consideration is dedicated to the management of hepatitis B within specific populations, such as pregnant women and children, thereby accentuating the distinctive considerations and challenges confronted when addressing the healthcare needs of these cohorts. Prevention strategies, encompassing vaccination programs and public health interventions, are exhaustively scrutinized as fundamental pillars in ameliorating the prevalence and dissemination of hepatitis B. Furthermore, the article casts its gaze upon the future, engaging in a comprehensive discourse regarding forthcoming avenues in hepatitis B research and therapeutic interventions. These encompass novel antiviral therapies, immunotherapies, disease monitoring biomarkers, gene therapy endeavors, enhanced diagnostic instruments, and the establishment of global collaborations to efficaciously tackle this momentous global health concern. In summary, this meticulously crafted review article presents a comprehensive synthesis of hepatitis B, encompassing its discovery, epidemiology, modes of transmission, clinical manifestations, diagnostic modalities, therapeutic alternatives, management within specific populations, prevention strategies, and forthcoming research and treatment directions. Consequently, this article stands as an indispensable resource for researchers, healthcare practitioners, and policymakers engaged in the battle against hepatitis B and the advancement of patient outcomes.

Files

17 WJPSR 264.pdf

Files (794.0 kB)

Name Size Download all
md5:5bc059a35adb17a7dedf37b2cccde14c
794.0 kB Preview Download

Additional details

References

  • Humans IWGotEoCRt. HEPATITIS B VIRUS. Hepatitis Viruses: International Agency for Research on Cancer, 1994.
  • Zuckerman AJ. Hepatitis viruses. Medical Microbiology 4th edition. 1996.
  • Block TM, Alter HJ, London WT, Bray M. A historical perspective on the discovery and elucidation of the hepatitis B virus. Antiviral Res., 2016; 131: 109-23.
  • Burns GS, Thompson AJ. Viral hepatitis B: clinical and epidemiological characteristics. Cold Spring Harb Perspect Med, 2014; 4(12): a024935.
  • MacLachlan JH, Cowie BC. Hepatitis B virus epidemiology. Cold Spring Harb Perspect Med, 2015; 5(5): a021410.
  • Nebbia G, Peppa D, Maini MK. Hepatitis B infection: current concepts and future challenges. Qjm, 2012; 105(2): 109-13.
  • Dandri M, Locarnini S. New insight in the pathobiology of hepatitis B virus infection. Gut, 2012; 61 Suppl 1: i6-17.
  • Krajden M, McNabb G, Petric M. The laboratory diagnosis of hepatitis B virus. Can J Infect Dis Med Microbiol, 2005; 16(2): 65-72.
  • Song JE, Kim DY. Diagnosis of hepatitis B. Ann Transl Med, 2016; 4(18): 338.
  • Halegoua-De Marzio D, Hann HW. Then and now: the progress in hepatitis B treatment over the past 20 years. World J Gastroenterol, 2014; 20(2): 401-13.
  • Zoulim F. Hepatitis B virus resistance to antiviral drugs: where are we going? Liver Int, 2011; 31 Suppl 1: 111-6.
  • Guan TH, Htut HN, Davison CM, Sebastian S, Bartels SA, Aung SM, et al. Implementation of a neonatal hepatitis B immunization program in rural Karenni State, Myanmar: A mixed-methods study. PLoS One, 2021; 16(12): e0261470.
  • Salama, II, Sami SM, Salama SI, Abdel-Latif GA, Shaaban FA, Fouad WA, et al. Current and novel modalities for management of chronic hepatitis B infection. World J Hepatol, 2023; 15(5): 585-608.
  • Pan CQ, Zhang JX. Natural History and Clinical Consequences of Hepatitis B Virus Infection. Int J Med Sci, 2005; 2(1): 36-40.
  • Al-Mahtab M, Roy PP, Khan MSI, Akbar SM. Nobel Prize for the Discovery of Hepatitis B and C: A Brief History in Time. Euroasian J Hepatogastroenterol, 2020; 10(2): 98-100.
  • Khuroo MS, Sofi AA. The Discovery of Hepatitis Viruses: Agents and Disease. J Clin Exp Hepatol, 2020; 10(4): 391-401.
  • Liang TJ, Block TM, McMahon BJ, Ghany MG, Urban S, Guo JT, et al. Present and future therapies of hepatitis B: From discovery to cure. Hepatology, 2015; 62(6): 1893-908.
  • Hou J, Liu Z, Gu F. Epidemiology and Prevention of Hepatitis B Virus Infection. Int J Med Sci, 2005; 2(1): 50-7.
  • Martyn E, Eisen S, Longley N, Harris P, Surey J, Norman J, et al. The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda. Elife, 2023; 12.
  • Fofana DB, Somboro AM, Maiga M, Kampo MI, Diakité B, Cissoko Y, et al. Hepatitis B Virus in West African Children: Systematic Review and Meta-Analysis of HIV and Other Factors Associated with Hepatitis B Infection. Int J Environ Res Public Health, 2023; 20(5).
  • Kiire CF. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. Gut, 1996; 38 Suppl 2(Suppl 2): S5-12.
  • Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology, 2012; 56(2): 422-33.
  • Franco E, Bagnato B, Marino MG, Meleleo C, Serino L, Zaratti L. Hepatitis B: Epidemiology and prevention in developing countries. World J Hepatol, 2012; 4(3): 74-80.
  • El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 2012; 142(6): 1264-73.e1.
  • Keshavarz K, Kebriaeezadeh A, Alavian SM, Akbari Sari A, Abedin Dorkoosh F, Keshvari M, et al. Economic burden of hepatitis B virus-related diseases: evidence from iran. Hepat Mon, 2015; 15(4): e25854.
  • Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis, 2002; 2(7): 395-403.
  • Levengood TW, Yoon GH, Davoust MJ, Ogden SN, Marshall BDL, Cahill SR, et al. Supervised Injection Facilities as Harm Reduction: A Systematic Review. Am J Prev Med, 2021; 61(5): 738-49.
  • Li T, Su S, Zhao Y, Deng R, Fan M, Wang R, et al. Barriers to the Prevention and Control of Hepatitis B and Hepatitis C in the Community of Southwestern China: A Qualitative Research. Int J Environ Res Public Health, 2019; 16(2).
  • Athalye S, Khargekar N, Shinde S, Parmar T, Chavan S, Swamidurai G, et al. Exploring risk factors and transmission dynamics of Hepatitis B infection among Indian families: Implications and perspective. J Infect Public Health, 2023; 16(7): 1109-14.
  • Edmunds WJ, Medley GF, Nokes DJ. The transmission dynamics and control of hepatitis B virus in The Gambia. Stat Med, 1996; 15(20): 2215-33.
  • Sabeena S, Ravishankar N. Horizontal Modes of Transmission of Hepatitis B Virus (HBV): A Systematic Review and Meta-Analysis. Iran J Public Health, 2022; 51(10): 2181-93.
  • Kwon SY, Lee CH. Epidemiology and prevention of hepatitis B virus infection. Korean J Hepatol, 2011; 17(2): 87-95.
  • Weldebrhan D, Berhe H, Tesfay Y. Risk Factors for Hepatitis B Virus Infection in North Ethiopia: A Case-Control Study. Hepat Med, 2023; 15: 79-91.
  • N RH. Risk factors of hepatitis B virus infection among blood donors in Duhok city, Kurdistan Region, Iraq. Caspian J Intern Med, 2018; 9(1): 22-6.
  • Liang TJ. Hepatitis B: the virus and disease. Hepatology, 2009; 49(5 Suppl): S13-21.
  • Seeger C, Mason WS. Molecular biology of hepatitis B virus infection. Virology, 2015; 479-480: 672-86.
  • Venkatakrishnan B, Zlotnick A. The Structural Biology of Hepatitis B Virus: Form and Function. Annu Rev Virol, 2016; 3(1): 429-51.
  • Beck J, Nassal M. Hepatitis B virus replication. World J Gastroenterol, 2007; 13(1): 48-64.
  • Tsukuda S, Watashi K. Hepatitis B virus biology and life cycle. Antiviral Research, 2020; 182: 104925.
  • Noordeen F. Hepatitis B virus infection: An insight into infection outcomes and recent treatment options. Virusdisease, 2015; 26(1-2): 1-8.
  • Jia J, Li Y, Wei C, Guo R, Xu H, Jia Y, et al. Factors associated with disease progression and viral replication in patients with chronic hepatitis B virus infection. Exp Ther Med, 2019; 17(6): 4730-40.
  • Nguyen MH, Wong G, Gane E, Kao JH, Dusheiko G. Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clin Microbiol Rev, 2020; 33(2).
  • Valsamakis A. Molecular testing in the diagnosis and management of chronic hepatitis B. Clin Microbiol Rev, 2007; 20(3): 426-39, table of contents.
  • Hall P, Cash J. What is the real function of the liver 'function' tests? Ulster Med J, 2012; 81(1): 30-6.
  • Taouli B, Ehman RL, Reeder SB. Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol, 2009; 193(1): 14-27.
  • Han SH, Saab S, Martin P. Acute Viral Hepatitis. Curr Treat Options Gastroenterol, 2000; 3(6): 481-6.
  • Colvin HM, Mitchell AE. Surveillance. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C: National Academies Press (US); 2010.
  • Wang CY, Zhao P, Liu WW. Acute liver failure caused by severe acute hepatitis B: a case series from a multi-center investigation. Ann Clin Microbiol Antimicrob, 2014; 13: 23.
  • Chang MH, Chen DS. Prevention of hepatitis B. Cold Spring Harb Perspect Med, 2015; 5(3): a021493.
  • Cholongitas E, Tziomalos K, Pipili C. Management of patients with hepatitis B in special populations. World J Gastroenterol, 2015; 21(6): 1738-48.
  • Singh A, Kumar J, Kumar V. Chronic Hepatitis B Infection: Current and Emerging Therapeutic Strategies. Curr Top Med Chem, 2023; 23(18): 1727-52.
  • Alexopoulou A, Vasilieva L, Karayiannis P. New Approaches to the Treatment of Chronic Hepatitis B. J Clin Med, 2020; 9(10).
  • Khoo T, Lam D, Olynyk JK. Impact of modern antiviral therapy of chronic hepatitis B and C on clinical outcomes of liver disease. World J Gastroenterol, 2021; 27(29): 4831-45.
  • De Clercq E, Férir G, Kaptein S, Neyts J. Antiviral treatment of chronic hepatitis B virus (HBV) infections. Viruses, 2010; 2(6): 1279-305.
  • Andersson KL, Chung RT. Monitoring during and after antiviral therapy for hepatitis B. Hepatology, 2009; 49(5 Suppl): S166-73.
  • Papastergiou V, Tsochatzis E, Burroughs AK. Non-invasive assessment of liver fibrosis. Ann Gastroenterol, 2012; 25(3): 218-31.
  • Shyr ZA, Cheng YS, Lo DC, Zheng W. Drug combination therapy for emerging viral diseases. Drug Discov Today, 2021; 26(10): 2367-76.
  • Tsachouridou O, Georgiou A, Naoum S, Vasdeki D, Papagianni M, Kotoreni G, et al. Factors associated with poor adherence to vaccination against hepatitis viruses, streptococcus pneumoniae and seasonal influenza in HIV-infected adults. Hum Vaccin Immunother, 2019; 15(2): 295-304.
  • Buzzetti E, Linden A, Best LM, Madden AM, Roberts D, Chase TJG, et al. Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database Syst Rev, 2021; 6(6): Cd013156.
  • Ayoub WS, Cohen E. Hepatitis B Management in the Pregnant Patient: An Update. J Clin Transl Hepatol, 2016; 4(3): 241-7.
  • Gentile I, Borgia G. Vertical transmission of hepatitis B virus: challenges and solutions. Int J Womens Health, 2014; 6: 605-11.
  • Broderick A, Jonas MM. Management of hepatitis B in children. Clin Liver Dis, 2004; 8(2): 387-401.
  • Bessone F, Dirchwolf M. Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations. World J Hepatol, 2016; 8(8): 385-94.
  • Pol S. Management of HBV in immunocompromised patients. Liver Int, 2013; 33 Suppl 1: 182-7.
  • Mast EE, Alter MJ, Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine, 1999; 17(13-14): 1730-3.